cyc 202 has been researched along with fluorescein-5-isothiocyanate in 1 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (fluorescein-5-isothiocyanate) | Trials (fluorescein-5-isothiocyanate) | Recent Studies (post-2010) (fluorescein-5-isothiocyanate) |
---|---|---|---|---|---|
979 | 7 | 393 | 8,493 | 33 | 2,090 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Indorato, RL; Lacroix, F; Margolis, RL; Panopoulos, A; Skoufias, DA | 1 |
1 other study(ies) available for cyc 202 and fluorescein-5-isothiocyanate
Article | Year |
---|---|
Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed.
Topics: 2-Aminopurine; CDC2 Protein Kinase; Coloring Agents; Cysteine Proteinase Inhibitors; Drug Interactions; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; HCT116 Cells; HeLa Cells; Humans; Hydrolysis; Lactams; Leupeptins; Mitosis; Phosphoprotein Phosphatases; Propidium; Protein Kinase Inhibitors; Purines; Roscovitine | 2007 |